What is Revena?
Founded by Diogo Freitas and Mateus Noronha, Revena is a healthtech company specializing in the development of AI agents designed to automate the generation of medical bills from clinical records and payer rules. The company's platform seamlessly integrates with hospital electronic medical record systems. By leveraging generative AI, Revena interprets complex clinical histories and insurance contracts to automatically produce compliant medical bills. Currently operating with hospitals in Brazil, Revena's solutions are instrumental in streamlining billing operations and enhancing the overall operational efficiency within healthcare facilities.
How much funding has Revena raised?
Revena has raised a total of $9M across 2 funding rounds:
Angel/Pre-Seed
$1M
Seed
$8M
Angel/Pre-Seed (2024): $1M, investors not publicly disclosed
Seed (2026): $8M led by Flourish, Caravela Capital, and Canary
Key Investors in Revena
Flourish
Flourish Ventures is an early-stage global venture capital firm that invests in fintech founders, focusing on mission-driven entrepreneurs. The firm offers a unique approach to nurturing founders through development workshops and personalized support, emphasizing the importance of mental resilience. With a portfolio of over 100 companies across five continents, Flourish is committed to creating fair financial systems and empowering small businesses. Their expertise spans various investment themes, including digital banking, insurtech, and embedded finance, making them a valuable partner for startups in the fintech ecosystem.
Caravela Capital
Caravela Capital is a Brazilian venture capital firm that focuses on investing in early-stage companies across Latin America. The firm aims to support innovative startups by providing the necessary capital and resources for growth. Their target clients include emerging businesses in various sectors looking for investment to scale their operations. Caravela Capital is committed to fostering entrepreneurship and driving economic development in the region.
Canary
Canary is the first partner of choice of the best founders in LatAm. We are co-founders of the companies we back, from the ground up, supported by the best community of builders.
What's next for Revena?
The recent major strategic investment, alongside the overall enterprise-level funding, positions Revena for significant expansion and technological advancement. This capital injection will likely fuel further research and development into its AI agent capabilities, potentially broadening its application beyond current hospital integrations. The company's focus on automating a critical and often complex aspect of healthcare administration suggests a strategic move towards capturing a larger market share in the healthtech sector, particularly in regions with complex billing regulations like Brazil. Future growth may involve expanding its service offerings, forging new partnerships, and enhancing its platform's predictive analytics for revenue cycle management.
See full Revena company page
